Hyperglycaemia after dolutegravir-based antiretroviral treatment in people living with human immunodeficiency virus: A case series
Antiretroviral therapy involves a combination of human immunodeficiency virus (HIV) medicines recommended for everyone who has HIV which helps them to live longer, and healthier, and reduces the risk of HIV transmission. Dolutegravir (DTG)-based antiretroviral treatment (ART) is preferred as the fir...
Saved in:
Main Authors: | Keerthana Sagadevan, Pilla S. Surya Durga Devi, Katikatala Swaroopa, P. Sathish Sreenivas, R. Srinivasa Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Clinical and Scientific Research |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jcsr.jcsr_140_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief communication: virological outcomes and dolutegravir resistance mutations in HIV-infected patients: a multicenter retrospective cohort study in Mozambique
by: Anna Maria Doro Altan, et al.
Published: (2025-01-01) -
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
by: Hernando Knobel, et al.
Published: (2023-12-01) -
Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review
by: William R. Short, et al.
Published: (2024-12-01) -
HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
by: Nalia Ismael, et al.
Published: (2025-01-01) -
Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study
by: Rachawit Setpakdee, et al.
Published: (2025-02-01)